|
Wednesday, June 14, 2006 Sarbox is the bane of every multinational business with a presence in the US. The Sarbannes, you might say. The corporate governance rules being adopted in the US under this moniker are well meant, no doubt. But they add a layer of complexity and bureaucracy that is making plenty of US firms wonder if they are really worthwhile. The absence of Sarbox has been a key part in the success of London exchanges in attracting business from non-US companies. If, as the FSA suggests, Sarbox could come here it is likely to make it harder for Nasdaq and LSE to stitch a deal together. It would be an awful burden on British business as well. FSA: Sarbanes-Oxley could come to London Previous articles SAG Gets Stats on Sarbanes-Oxley 404, Restatements...
|
Sponsored by:
Kumquat: Get the feedback you deserve
Learn more
FREE to Inside Sarbanes Oxley readers

|
About inside Sarbanes-Oxley inside Sarbanes Oxley is dedicated to finding the best sources of news and information on the changing landscape of Sarbanes Oxley and compliance. Whether you call it SOX, Sarbox, or the Sarbanes-Oxley Act of 2002, look no further than inside Sarbanes Oxley. More Copyright © 2004-2006, Inside Sarbanes-Oxley
|
Additional resources Try these recently updated resources: RSS Feed Interested in staying up-to-date on all the latest Sarbanes-Oxley news? Subscribe to the inside Sarbanes-Oxley RSS feed and get all of the latest news on SOX delivered directly to your feed reader. inside
Sarbanes-Oxley RSS Feed
|